Quick Answer
OptimizeRx Corp reported Operating Income Loss of $11.69 million for the year ending 2025.
- OptimizeRx Corp showed an increase of +185.3% in Operating Income Loss from 2024 to 2025.
- This data is from OptimizeRx Corp's annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), OptimizeRx Corp's Operating Income Loss has grown by 733.3%.
- Historical annual values: Fiscal year 2025: $11.69 million | Fiscal year 2024: -$13.71 million | Fiscal year 2023: -$26.40 million | Fiscal year 2022: -$12.29 million | Fiscal year 2021: $361.1 thousand | Fiscal year 2020: -$2.14 million | Fiscal year 2019: -$3.69 million | Fiscal year 2018: $180.1 thousand | Fiscal year 2017: -$2.13 million | Fiscal year 2016: -$1.58 million | Fiscal year 2015: -$597.4 thousand | Fiscal year 2014: -$1.03 million | Fiscal year 2013: -$267.5 thousand | Fiscal year 2012: -$454.9 thousand | Fiscal year 2011: -$1.45 million | Fiscal year 2010: -$1.85 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: